Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 98,822 | 96,131 | 91,588 | 79,437 | 85,735 |
| Cost of Goods | 1,354 | 1,275 | 1,384 | 1,268 | 1,254 |
| Gross Profit | 97,468 | 94,856 | 90,204 | 78,169 | 84,481 |
| Operating Expenses | 61,158 | 58,899 | 58,645 | 58,799 | 54,225 |
| Operating Income | 36,664 | 36,232 | 31,943 | 19,638 | 30,510 |
| Other Income | 72 | 72 | 110 | 275 | 297 |
| Pre-tax Income | 36,736 | 36,304 | 32,053 | 19,913 | 30,807 |
| Income Tax | 16,349 | -5,833 | 5,530 | -3,552 | 4,813 |
| Net Income Continuous | 20,387 | 42,137 | 26,523 | 23,465 | 25,994 |
| Net Income | $20,387 | $42,137 | $26,523 | $23,465 | $25,994 |
| EPS Basic Total Ops | 0.28 | 0.26 | 0.23 | 0.20 | 0.22 |
| EPS Basic Continuous Ops | 0.18 | 0.36 | 0.23 | 0.20 | 0.22 |
| EPS Diluted Total Ops | 0.26 | 0.24 | 0.21 | 0.18 | 0.20 |
| EPS Diluted Continuous Ops | 0.17 | 0.34 | 0.21 | 0.18 | 0.20 |
| EBITDA(a) | $42,953 | $37,003 | $31,505 | $21,575 | $31,072 |